Michelson Medical Research Foundation’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.02M | Hold |
158,160
| – | – | 8.65% | 5 |
|
|
2025
Q1 | $8.04M | Hold |
158,160
| – | – | 6.73% | 7 |
|
|
2024
Q4 | $7.56M | Sell |
158,160
-203,000
| -56% | -$9.71M | 6.34% | 5 |
|
|
2024
Q3 | $19.1M | Hold |
361,160
| – | – | 13.45% | 1 |
|
|
2024
Q2 | $17.8M | Hold |
361,160
| – | – | 15.35% | 1 |
|
|
2024
Q1 | $18.1M | Hold |
361,160
| – | – | 10.98% | 2 |
|
|
2023
Q4 | $7.3M | Hold |
361,160
| – | – | 4.81% | 9 |
|
|
2023
Q3 | $15.8M | Buy |
361,160
+55,285
| +18% | +$2.42M | 10.66% | 2 |
|
|
2023
Q2 | $14.1M | Hold |
305,875
| – | – | 10.05% | 2 |
|
|
2023
Q1 | $13.8M | Hold |
305,875
| – | – | 10.83% | 2 |
|
|
2022
Q4 | $12.8M | Buy |
+305,875
| New | +$12.8M | 8.31% | 6 |
|